Hutchison China MediTech Limited
-
Ticker
HCM
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 501-1000 Employees
- Based in Central, Hong Kong
Hutchison China MediTech Limited, known as Chi-Med, is an innovative biopharmaceutical company aiming to become a global leader in the discovery, development and commercialisation of targeted therapies and immunotherapies in oncology and immunological diseases.
REPORT RATINGS
4.7 / 5.0 (74)
Hutchison China MediTech Limited reports have an aggregate usefulness score of 4.7 based on 74 reviews.
Hutchison China MediTech Limited
Most Recent Annual Report
MOST RECENT
2023 Annual Report
Older/Archived Annual Reports